NERV

Value Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25 TTM Total revenue 0-8 376-21.11 K-6 246-20.82 K -56.55 K Gross profit 0-8 376-21.11 K-6 246-20.82 K -56.55 K Operating expenses 4.52 M3.9 M3.37 M2.84 M4.98 M 15.1 M Selling/general/admin expenses 2.54 M2.54 M2.08 M1.92 M2.81 M 9.34 M Research & development 1.98 M1.36 M1.3 M925.38 K2.17 M 5.76 M Operating income -4.52 M-3.9 M-3.37 M-2.84 M-4.98 M -15.1 M Non-Operating Income, Total 250.11 K149.91 K115.56 K100.39 K525.7 K 891.57 K Interest expense, net of interest capitalized ————— — Non-Operating Income, excl. Interest Expenses 250.11 K149.91 K115.56 K100.39 K525.7 K 891.57 K Unusual income/expense ————— — Pretax income -4.27 M-3.75 M-3.26 M-2.74 M-4.46 M -14.21 M Equity in earnings ————— — Taxes ————2.98 M — Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations -4.27 M-3.75 M-3.26 M-2.74 M-283.67 M -293.42 M Discontinued operations ————— — Net income -4.27 M-3.75 M-3.26 M-2.74 M-283.67 M -293.42 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders -4.27 M-3.75 M-3.26 M-2.74 M-283.67 M -293.42 M Basic earnings per share (Basic EPS) -0.56-0.5-0.43-0.36-33.38 -34.67 Diluted earnings per share (Diluted EPS) -0.56-0.5-0.43-0.36-33.38 -34.67 Average basic shares outstanding 7.57 M7.57 M7.57 M7.57 M8.46 M 31.17 M Diluted shares outstanding 7.57 M7.57 M7.57 M7.57 M8.46 M 31.17 M EBITDA ————— — EBIT -4.52 M-3.91 M-3.4 M-2.85 M-5 M -15.16 M Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) ————— —